Zimran A - Search Results

1

Long-Term Treatment of Gaucher Disease with Velaglucerase Alfa in ERT-Naïve Patients from the Gaucher Outcome Survey (GOS) Registry.

Deegan P, Lau H, Elstein D, Fernandez-Sasso D, Giraldo P, Hughes D, Zimran A, Istaiti M, Gadir N, Botha J, Revel-Vilk S; GOS Study Group. Deegan P, et al. Among authors: zimran a. J Clin Med. 2024 May 9;13(10):2782. doi: 10.3390/jcm13102782. J Clin Med. 2024. PMID: 38792324 Free PMC article.

2

Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients.

Zimran A, Kay A, Gelbart T, Garver P, Thurston D, Saven A, Beutler E. Zimran A, et al. Medicine (Baltimore). 1992 Nov;71(6):337-53. Medicine (Baltimore). 1992. PMID: 1435229

3

Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype.

Abrahamov A, Elstein D, Gross-Tsur V, Farber B, Glaser Y, Hadas-Halpern I, Ronen S, Tafakjdi M, Horowitz M, Zimran A. Abrahamov A, et al. Among authors: zimran a. Lancet. 1995 Oct 14;346(8981):1000-3. doi: 10.1016/s0140-6736(95)91688-1. Lancet. 1995. PMID: 7475546

4

[Frequency of the Gaucher mutation among recent Russian immigrants].

Hodish I, Elstein D, Abrahamov A, Lonshakova N, Zimran A. Hodish I, et al. Among authors: zimran a. Harefuah. 1995 Jun 15;128(12):757-8, 824. Harefuah. 1995. PMID: 7557682 Hebrew.

5

Recent advances in diagnosis and therapy in Gaucher's disease.

Elstein D, Zimran A. Elstein D, et al. Among authors: zimran a. Isr J Med Sci. 1995 Aug;31(8):505-9. Isr J Med Sci. 1995. PMID: 7635703 Review. No abstract available.

6

Outcome of partial splenectomy for type I Gaucher disease.

Zimran A, Elstein D, Schiffmann R, Abrahamov A, Goldberg M, Bar-Maor JA, Brady RO, Guzzetta PC, Barton NW. Zimran A, et al. J Pediatr. 1995 Apr;126(4):596-7. doi: 10.1016/s0022-3476(95)70358-6. J Pediatr. 1995. PMID: 7699540

7

Replacement therapy with imiglucerase for type 1 Gaucher's disease.

Zimran A, Elstein D, Levy-Lahad E, Zevin S, Hadas-Halpern I, Bar-Ziv Y, Foldes J, Schwartz AJ, Abrahamov A. Zimran A, et al. Lancet. 1995 Jun 10;345(8963):1479-80. doi: 10.1016/s0140-6736(95)91038-7. Lancet. 1995. PMID: 7769903 Clinical Trial.

8

Enzyme replacement therapy in type 1 and type 3 Gaucher's disease.

Zimran A, Elstein D, Abrahamov A. Zimran A, et al. Lancet. 1995 Feb 18;345(8947):451-2. doi: 10.1016/s0140-6736(95)90432-8. Lancet. 1995. PMID: 7853968 No abstract available.

9

HCG contamination of alglucerase: clinical implications in low-dose regimen.

Cohen Y, Elstein D, Abrahamov A, Hirsch H, Zimran A. Cohen Y, et al. Among authors: zimran a. Am J Hematol. 1994 Nov;47(3):235-6. doi: 10.1002/ajh.2830470317. Am J Hematol. 1994. PMID: 7942791

10

The selective advantage of Gaucher's disease: TB or not TB?

Kannai R, Elstein D, Weiler-Razell D, Zimran A. Kannai R, et al. Among authors: zimran a. Isr J Med Sci. 1994 Dec;30(12):911-2. Isr J Med Sci. 1994. PMID: 8002277 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

363 results

Search Page

Filters